Molecular Docking vs. QSAR: How Smart Computing Shapes ADMET Decisions
Why ADMET Needs a Better Plan Most drug projects begin with bright hopes and a pile of molecules that look good on paper. Then reality walks in. A compound that seemed like a star in early screens may vanish in the gut, stick to plasma proteins, clog a liver enzyme,